168 related articles for article (PubMed ID: 38331909)
1. Surgical outcomes and perioperative risk factors of patients with interstitial lung disease after pulmonary resection.
Huang C; Sun YG; Ma C; Jiao P; Wu QJ; Tian WX; Yu HB; Tong HF
J Cardiothorac Surg; 2024 Feb; 19(1):72. PubMed ID: 38331909
[TBL] [Abstract][Full Text] [Related]
2. [Surgical Treatment of Lung Cancer Combined with Interstitial Lung Disease].
Huang C; Ma C; Wu Q; Jiao P; Sun Y; Tian W; Yu H; Huang W; Wang Y; Tong H
Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):343-350. PubMed ID: 32429636
[TBL] [Abstract][Full Text] [Related]
3. Impact of interstitial lung disease on postoperative morbidity and 90-day mortality after pulmonary resection.
Shao W; Huang J; Feng H; Sun H; Ren Y; Wang X; Zhang Z; Liu D
Transl Cancer Res; 2020 Feb; 9(2):1151-1159. PubMed ID: 35117459
[TBL] [Abstract][Full Text] [Related]
4. Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease.
Tsutani Y; Mimura T; Kai Y; Ito M; Misumi K; Miyata Y; Okada M
J Thorac Cardiovasc Surg; 2017 Sep; 154(3):1089-1096.e1. PubMed ID: 28483268
[TBL] [Abstract][Full Text] [Related]
5. High preoperative C-reactive protein level is a risk factor for acute exacerbation of interstitial lung disease after non-pulmonary surgery.
Takao S; Masuda T; Yamaguchi K; Sakamoto S; Horimasu Y; Nakashima T; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Hattori N
Medicine (Baltimore); 2019 Feb; 98(5):e14296. PubMed ID: 30702600
[TBL] [Abstract][Full Text] [Related]
6. Is operation safe for lung cancer patients with interstitial lung disease on computed tomography?
Tang H; Ren Y; She Y; Dai C; Wang T; Su H; Sun W; Jiang G; Chen C
Ther Adv Respir Dis; 2020; 14():1753466620971137. PubMed ID: 33167797
[TBL] [Abstract][Full Text] [Related]
7. The Interstitial Lung Disease-Gender-Age-Physiology Index Can Predict the Prognosis in Surgically Resected Patients with Interstitial Lung Disease and Concomitant Lung Cancer.
Ueno F; Kitaguchi Y; Shiina T; Asaka S; Yasuo M; Wada Y; Kinjo T; Yoshizawa A; Hanaoka M
Respiration; 2020; 99(1):9-18. PubMed ID: 31554007
[TBL] [Abstract][Full Text] [Related]
8. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer.
Sato T; Teramukai S; Kondo H; Watanabe A; Ebina M; Kishi K; Fujii Y; Mitsudomi T; Yoshimura M; Maniwa T; Suzuki K; Kataoka K; Sugiyama Y; Kondo T; Date H;
J Thorac Cardiovasc Surg; 2014 May; 147(5):1604-1611.e3. PubMed ID: 24267779
[TBL] [Abstract][Full Text] [Related]
9. Associations between Comorbidities and Acute Exacerbation of Interstitial Lung Disease after Primary Lung Cancer Surgery.
Kato T; Miyoshi S; Hamada C; Sano Y; Nogami N; Yamaguchi O; Hamaguchi N
Acta Med Okayama; 2023 Jun; 77(3):301-309. PubMed ID: 37357631
[TBL] [Abstract][Full Text] [Related]
10. Chest-tube drainage is a sign of acute exacerbation of interstitial lung disease associated with lung cancer.
Maniwa T; Isaka M; Nakagawa K; Ohde Y; Okumura T; Endo M; Kondo H
Surg Today; 2013 Apr; 43(4):408-11. PubMed ID: 23180119
[TBL] [Abstract][Full Text] [Related]
11. Predictive role of circulatory HMGB1 in postoperative acute exacerbation of interstitial lung disease in lung cancer patients.
Yamaguchi K; Nakao S; Iwamoto H; Kagimoto A; Handa Y; Sakamoto S; Horimasu Y; Masuda T; Mimae T; Miyamoto S; Nakashima T; Tsutani Y; Fujitaka K; Miyata Y; Hamada H; Okada M; Hattori N
Sci Rep; 2021 May; 11(1):10105. PubMed ID: 33980944
[TBL] [Abstract][Full Text] [Related]
12. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of serum oncomarkers for patients hospitalized with acute exacerbation of interstitial lung disease.
Ba C; Jiang C; Wang H; Shi X; Jin J; Fang Q
Ther Adv Respir Dis; 2024; 18():17534666241250332. PubMed ID: 38757948
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum D-dimer level is associated with an increased risk of acute exacerbation in interstitial lung disease.
Ishikawa G; Acquah SO; Salvatore M; Padilla ML
Respir Med; 2017 Jul; 128():78-84. PubMed ID: 28610674
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of the short-term outcomes of surgical treatment for non-small cell lung cancer via video assisted thoracoscopic surgery and open thoracotomy].
Mu JW; Zhang BH; Li N; Lü F; Mao YS; Xue Q; Gao SG; Zhao J; Wang DL; Li ZS; Gao YS; Zhang LZ; Huang JF; Shao K; Feng FY; Zhao L; Li J; Cheng GY; Sun KL; He J
Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):301-5. PubMed ID: 22781045
[TBL] [Abstract][Full Text] [Related]
16. Predicting Severe Postoperative Complication in Patients With Lung Cancer and Interstitial Pneumonia.
Ohsawa M; Tsutani Y; Fujiwara M; Mimae T; Miyata Y; Okada M
Ann Thorac Surg; 2020 Apr; 109(4):1054-1060. PubMed ID: 31887276
[TBL] [Abstract][Full Text] [Related]
17. Low forced vital capacity predicts cytotoxic chemotherapy-associated acute exacerbation of interstitial lung disease in patients with lung cancer.
Enomoto Y; Inui N; Kato T; Baba T; Karayama M; Nakamura Y; Ogura T; Suda T
Lung Cancer; 2016 Jun; 96():63-7. PubMed ID: 27133752
[TBL] [Abstract][Full Text] [Related]
18. Video-assisted thoracoscopic lobectomy in non-small-cell lung cancer patients with chronic obstructive pulmonary disease is associated with lower pulmonary complications than open lobectomy: a propensity score-matched analysis.
Jeon JH; Kang CH; Kim HS; Seong YW; Park IK; Kim YT; Kim JH
Eur J Cardiothorac Surg; 2014 Apr; 45(4):640-5. PubMed ID: 24052605
[TBL] [Abstract][Full Text] [Related]
19. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
[TBL] [Abstract][Full Text] [Related]
20. The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer.
Masuda T; Hirano C; Horimasu Y; Nakashima T; Miyamoto S; Iwamoto H; Ohshimo S; Fujitaka K; Hamada H; Hattori N
Cancer Chemother Pharmacol; 2018 Jan; 81(1):131-139. PubMed ID: 29143072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
